This report studies the global Deferasirox market status and forecast, categorizes the global Deferasirox market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/global-deferasirox-sales-market-report-2018
The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood. Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.
The global Deferasirox market is valued at 2270 million US$ in 2017 and will reach 3230 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2018–2025.
The major players covered in this report
- Novartis
- Cipla
- Sun Pharma
- Natco Pharma
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- 500 mg/Tablet
- 250 mg/Tablet
- 125 mg/Tablet
- Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
- Transfusional Iron Overload
- NTDT Caused Iron Overload
The study objectives of this report are:
- To analyze and study the global Deferasirox sales, value, status (2013–2017) and forecast (2018–2025);
- To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
- Focuses on the key Deferasirox players, to study the sales, value, market share and development plans in future.
- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Deferasirox are as follows:
- History Year: 2013–2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
- Deferasirox Manufacturers
- Deferasirox Distributors/Traders/Wholesalers
- Deferasirox Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
Available Customizations
- With the given market data, We offers customizations according to the company’s specific needs. The following customization options are available for the report:
- Regional and country-level analysis of the Deferasirox market, by end-use.
- Detailed analysis and profiles of additional market players.
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/global-deferasirox-sales-market-report-2018
Table of content
Global Deferasirox Sales Market Report 2018
1 Deferasirox Market Overview
1.1 Product Overview and Scope of Deferasirox
1.2 Classification of Deferasirox by Product Category
1.2.1 Global Deferasirox Market Size (Sales) Comparison by Type (2013–2025)
1.2.2 Global Deferasirox Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 500 mg/Tablet
1.2.4 250 mg/Tablet
1.2.5 125 mg/Tablet
1.2.6 Others
1.3 Global Deferasirox Market by Application/End Users
1.3.1 Global Deferasirox Sales (Volume) and Market Share Comparison by Application (2013–2025)
1.3.1 Transfusional Iron Overload
1.3.2 NTDT Caused Iron Overload
2 Global Deferasirox Competition by Players/Suppliers, Type and Application
2.1 Global Deferasirox Market Competition by Players/Suppliers
2.1.1 Global Deferasirox Sales and Market Share of Key Players/Suppliers (2013–2018)
2.1.2 Global Deferasirox Revenue and Share by Players/Suppliers (2013–2018)
2.2 Global Deferasirox (Volume and Value) by Type
2.2.1 Global Deferasirox Sales and Market Share by Type (2013–2018)
2.2.2 Global Deferasirox Revenue and Market Share by Type (2013–2018)
2.3 Global Deferasirox (Volume and Value) by Region
2.3.1 Global Deferasirox Sales and Market Share by Region (2013–2018)
2.3.2 Global Deferasirox Revenue and Market Share by Region (2013–2018)
If You Have Any Question Related To This Report Contact Us @ https://www.24marketreports.com/enquire-now/global-deferasirox-sales-market-report-2018
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: help@24marketreports.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports